Supplementary Data from Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial

MLA

Michail Ignatiadis, et al. Supplementary Data from Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....743d26970674f2c86fb35d251731fc3d&authtype=sso&custid=ns315887.

APA

Michail Ignatiadis, Sarah-Jane Dawson, Christos Sotiriou, Sherene Loi, Martine Piccart, Jose Baselga, Jens Huober, Wolfgang Janni, Takayuki Ueno, Andrew Wardley, Stephen Chia, Daniela Rosa, Serena Di Cosimo, Vanessa Rodrik-Outmezguine, Debora Fumagalli, Marion Maetens, Evandro de Azambuja, Ghizlane Rouas, Ian Bradburry, … Françoise Rothé. (2023). Supplementary Data from Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial.

Chicago

Michail Ignatiadis, Sarah-Jane Dawson, Christos Sotiriou, Sherene Loi, Martine Piccart, Jose Baselga, Jens Huober, et al. 2023. “Supplementary Data from Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....743d26970674f2c86fb35d251731fc3d&authtype=sso&custid=ns315887.